AK
Akanda Corp.
AKAN · NASDAQ
$3.07 -0.65% (-$0.02)
1M -52.40%
Market Cap $97.1K
P/E Ratio -
Div. Yield -
ROE 1,202.24%
Piotroski F-Score Weak
2/9Valuation
100 /100
Cheap P/S 0.12x
P/B 0.02x
P/E N/A
Growth
100 /100
Growing Rev. growth 172.32%
EPS growth N/A
FCF growth N/A
Profitability
8 /100
Weak Gross margin 24.91%
Net margin 489.57%
Op. margin 523.80%
Quality
1 /100
Poor ROIC 94.67%
ROE 1,202.24%
ROA 51.76%
Debt
61 /100
Moderate Debt/Equity 0.08x
Current ratio 1.39x
Int. coverage -31.65x
Stability
4 /100
Unstable Beta 1.73x
Rev. volatility 3,615.67%
EPS volatility 9,796.97%
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre AKAN
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Katharyn Field
Employees
8
Headquarters
Toronto